Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers
GC Russell, Y Hamzaoui, D Rho, G Sutrave, JS Choi… - Cytotherapy, 2024 - Elsevier
CAR-T cell therapies have been successful in treating numerous hematologic malignancies
as the T cell can be engineered to target a specific antigen associated with the disease …
as the T cell can be engineered to target a specific antigen associated with the disease …
Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers
GC Russell, Y Hamzaoui, D Rho… - …, 2024 - mayoclinic.elsevierpure.com
CAR-T cell therapies have been successful in treating numerous hematologic malignancies
as the T cell can be engineered to target a specific antigen associated with the disease …
as the T cell can be engineered to target a specific antigen associated with the disease …
Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers
GC Russell, Y Hamzaoui, D Rho, G Sutrave… - … - pubmed.ncbi.nlm.nih.gov
CAR-T cell therapies have been successful in treating numerous hematologic malignancies
as the T cell can be engineered to target a specific antigen associated with the disease …
as the T cell can be engineered to target a specific antigen associated with the disease …
Synthetic biology approaches for enhancing safety and specificity of CAR-T cell therapies for solid cancers.
GC Russell, Y Hamzaoui, D Rho, G Sutrave, JS Choi… - …, 2024 - europepmc.org
CAR-T cell therapies have been successful in treating numerous hematologic malignancies
as the T cell can be engineered to target a specific antigen associated with the disease …
as the T cell can be engineered to target a specific antigen associated with the disease …